The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comprehensive analysis of genetic polymorphisms and irinotecan-induced adverse events in Japanese gastrointestinal cancer patients: A DMET microarray profiling study.
Hidekazu Kuramochi
No relevant relationships to disclose
Hitoshi Kanno
No relevant relationships to disclose
Tomotaka Uchiyama
No relevant relationships to disclose
Go Nakajima
No relevant relationships to disclose
Kayoko Saito
No relevant relationships to disclose
Kazuhiko Hayashi
No relevant relationships to disclose